MEGA Stock Overview
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Mega Lifesciences Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿41.25 |
| 52 Week High | ฿46.75 |
| 52 Week Low | ฿34.75 |
| Beta | 0.40 |
| 1 Month Change | -0.60% |
| 3 Month Change | -5.17% |
| 1 Year Change | 0.61% |
| 3 Year Change | 18.71% |
| 5 Year Change | 10.74% |
| Change since IPO | 93.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEGA | TH Pharmaceuticals | TH Market | |
|---|---|---|---|
| 7D | 0% | 2.0% | 0.2% |
| 1Y | 0.6% | 0.6% | -11.0% |
Return vs Industry: MEGA matched the TH Pharmaceuticals industry which returned 0.6% over the past year.
Return vs Market: MEGA exceeded the TH Market which returned -11% over the past year.
Price Volatility
| MEGA volatility | |
|---|---|
| MEGA Average Weekly Movement | 2.9% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in TH Market | 9.2% |
| 10% least volatile stocks in TH Market | 2.2% |
Stable Share Price: MEGA has not had significant price volatility in the past 3 months.
Volatility Over Time: MEGA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | n/a | Vivek Dhawan | www.megawecare.com |
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids’, men’s, and women’s care products.
Mega Lifesciences Public Company Limited Fundamentals Summary
| MEGA fundamental statistics | |
|---|---|
| Market cap | ฿35.96b |
| Earnings (TTM) | ฿1.99b |
| Revenue (TTM) | ฿15.72b |
18.0x
P/E Ratio2.3x
P/S RatioIs MEGA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEGA income statement (TTM) | |
|---|---|
| Revenue | ฿15.72b |
| Cost of Revenue | ฿8.59b |
| Gross Profit | ฿7.13b |
| Other Expenses | ฿5.14b |
| Earnings | ฿1.99b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
| Earnings per share (EPS) | 2.29 |
| Gross Margin | 45.37% |
| Net Profit Margin | 12.68% |
| Debt/Equity Ratio | 0.8% |
How did MEGA perform over the long term?
See historical performance and comparison